NDC 70518-2720

Candesartan Cilexetil and Hydrochlorothiazide

Candesartan Cilexetil And Hydrochlorothiazide

Candesartan Cilexetil and Hydrochlorothiazide is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Candesartan Cilexetil; Hydrochlorothiazide.

Product ID70518-2720_a6161d35-9a85-b91f-e053-2995a90aa0d2
NDC70518-2720
Product TypeHuman Prescription Drug
Proprietary NameCandesartan Cilexetil and Hydrochlorothiazide
Generic NameCandesartan Cilexetil And Hydrochlorothiazide
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2020-05-01
Marketing CategoryNDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC
Application NumberNDA021093
Labeler NameREMEDYREPACK INC.
Substance NameCANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
Active Ingredient Strength32 mg/1; mg/1
Pharm ClassesAngiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 70518-2720-0

90 TABLET in 1 BOTTLE, PLASTIC (70518-2720-0)
Marketing Start Date2020-05-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70518-2720-0 [70518272000]

Candesartan Cilexetil and Hydrochlorothiazide TABLET
Marketing CategoryNDA authorized generic
Application NumberNDA021093
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-05-01

Drug Details

NDC Crossover Matching brand name "Candesartan Cilexetil and Hydrochlorothiazide" or generic name "Candesartan Cilexetil And Hydrochlorothiazide"

NDCBrand NameGeneric Name
0378-3001Candesartan Cilexetil and Hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
0378-3002Candesartan Cilexetil and Hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
0378-3003Candesartan Cilexetil and Hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
33342-131Candesartan Cilexetil and HydrochlorothiazideCandesartan Cilexetil and Hydrochlorothiazide
33342-132Candesartan Cilexetil and HydrochlorothiazideCandesartan Cilexetil and Hydrochlorothiazide
33342-133Candesartan Cilexetil and HydrochlorothiazideCandesartan Cilexetil and Hydrochlorothiazide
43547-459candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
43547-460candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
43547-461candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
62559-660Candesartan Cilexetil and HydrochlorothiazideCandesartan Cilexetil and Hydrochlorothiazide
62559-661Candesartan Cilexetil and HydrochlorothiazideCandesartan Cilexetil and Hydrochlorothiazide
62559-662Candesartan Cilexetil and HydrochlorothiazideCandesartan Cilexetil and Hydrochlorothiazide
68382-194candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
68382-416candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
68382-195candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
70771-1326candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
70771-1325candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
70771-1327candesartan cilexetil and hydrochlorothiazidecandesartan cilexetil and hydrochlorothiazide
70518-2720Candesartan Cilexetil and HydrochlorothiazideCandesartan Cilexetil and Hydrochlorothiazide
0186-0162ATACAND HCTCandesartan cilexetil and Hydrochlorothiazide
0186-0322ATACAND HCTCandesartan cilexetil and Hydrochlorothiazide
62559-650ATACAND HCTCandesartan Cilexetil and Hydrochlorothiazide
62559-651ATACAND HCTCandesartan Cilexetil and Hydrochlorothiazide
62559-652ATACAND HCTCandesartan Cilexetil and Hydrochlorothiazide
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.